Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1296

1.

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET.

J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5.

PMID:
11238480
2.

Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.

Brochu M, Starling RD, Tchernof A, Matthews DE, Garcia-Rubi E, Poehlman ET.

J Clin Endocrinol Metab. 2000 Jul;85(7):2378-84.

PMID:
10902782
3.

The metabolically healthy but obese individual presents a favorable inflammation profile.

Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R.

J Clin Endocrinol Metab. 2005 Jul;90(7):4145-50.

PMID:
15855252
4.

Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?

Brochu M, Tchernof A, Turner AN, Ades PA, Poehlman ET.

Metabolism. 2003 May;52(5):599-604.

PMID:
12759890
5.

Identifying metabolically healthy but obese individuals in sedentary postmenopausal women.

Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R.

Obesity (Silver Spring). 2010 May;18(5):911-7. doi: 10.1038/oby.2009.364.

6.

Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study.

Karelis AD, Pasternyk SM, Messier L, St-Pierre DH, Lavoie JM, Garrel D, Rabasa-Lhoret R.

Appl Physiol Nutr Metab. 2007 Dec;32(6):1089-96.

PMID:
18059582
7.
8.

Relationship between the metabolic syndrome and physical activity energy expenditure: a MONET study.

Karelis AD, Lavoie ME, Messier V, Mignault D, Garrel D, Prud'homme D, Rabasa-Lhoret R.

Appl Physiol Nutr Metab. 2008 Apr;33(2):309-14. doi: 10.1139/H07-193.

PMID:
18347686
9.

Regional body fat distribution and metabolic profile in postmenopausal women.

Piché ME, Lapointe A, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S.

Metabolism. 2008 Aug;57(8):1101-7. doi: 10.1016/j.metabol.2008.03.015.

PMID:
18640388
10.

Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.

Malita FM, Messier V, Lavoie JM, Bastard JP, Rabasa-Lhoret R, Karelis AD.

Nutr Metab Cardiovasc Dis. 2010 Mar;20(3):173-9. doi: 10.1016/j.numecd.2009.03.005.

PMID:
19501492
11.

Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.

Zamboni M, Armellini F, Milani MP, De Marchi M, Todesco T, Robbi R, Bergamo-Andreis IA, Bosello O.

Int J Obes Relat Metab Disord. 1992 Jul;16(7):495-504.

PMID:
1323546
12.

Metabolic indices in relation to body composition changes during weight loss on Dexfenfluramine in obese women from two South African ethnic groups.

van der Merwe MT, Wing JR, Celgow LH, Gray IP, Lönn L, Joffe BI, Lönnroth PN.

Int J Obes Relat Metab Disord. 1996 Aug;20(8):768-76.

PMID:
8856402
13.

Change in plasma acylation stimulating protein during euglycaemic-hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study.

St-Pierre DH, Cianflone K, Smith J, Coderre L, Karelis AD, Imbeault P, Lavoie JM, Rabasa-Lhoret R.

Clin Endocrinol (Oxf). 2009 Apr;70(4):539-46. doi: 10.1111/j.1365-2265.2008.03353.x.

PMID:
18702682
14.

Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.

Ryan AS, Nicklas BJ, Berman DM.

Diabetes Care. 2002 Jan;25(1):127-33.

PMID:
11772913
15.
16.

Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant.

Tchernof A, Starling RD, Turner A, Shuldiner AR, Walston JD, Silver K, Poehlman ET.

Diabetes. 2000 Oct;49(10):1709-13.

PMID:
11016455
17.

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

Franco C, Brandberg J, Lönn L, Andersson B, Bengtsson BA, Johannsson G.

J Clin Endocrinol Metab. 2005 Mar;90(3):1466-74.

PMID:
15598680
18.

Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.

Fabbrini E, Cella M, McCartney SA, Fuchs A, Abumrad NA, Pietka TA, Chen Z, Finck BN, Han DH, Magkos F, Conte C, Bradley D, Fraterrigo G, Eagon JC, Patterson BW, Colonna M, Klein S.

Gastroenterology. 2013 Aug;145(2):366-74.e1-3. doi: 10.1053/j.gastro.2013.04.010.

19.

Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.

Peppa M, Koliaki C, Papaefstathiou A, Garoflos E, Katsilambros N, Raptis SA, Hadjidakis DI, Dimitriadis GD.

Obesity (Silver Spring). 2013 Sep;21(9):1807-14. doi: 10.1002/oby.20227.

20.

Comparison of VO2max and disease risk factors between perimenopausal and postmenopausal women.

Lynch NA, Ryan AS, Berman DM, Sorkin JD, Nicklas BJ.

Menopause. 2002 Nov-Dec;9(6):456-62.

PMID:
12439106
Items per page

Supplemental Content

Support Center